SCHEMBL14508259

SCHEMBL14508259

CC1(C)c2cc(-c3cccc(-c4ccc5ccccc5c4)c3)ccc2-c2ccc(-c3ccc4c(c3)C(C)(C)c3cc(-c5ccc6c(c5)C(C)(C)c5cc(-c7cccc(-c8nc9ccccc9nc8-c8ccccc8)c7)ccc5-6)ccc3-4)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 7/20 0.44
KDM4E B2RXH2 7/20 0.44
LMNA P02545 5/20 0.44
ALDH1A1 P00352 5/20 0.44
TDP1 Q9NUW8 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
ADORA2A P29274 3/20 0.44
ADORA1 P30542 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
KMT2A Q03164 2/20 0.41
GAA P10253 2/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41
MAPK1 P28482 1/20 0.40
RECQL P46063 1/20 0.40
AKT1 P31749 1/20 0.40
AKT2 P31751 1/20 0.40
PDE10A Q9Y233 1/20 0.39
ATM Q13315 1/20 0.39
TLR9 Q9NR96 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14508249 0.93 TDP1 (0.50) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL14508285 0.92 TDP1 (0.49) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL14508274 0.92 TDP1 (0.49) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL22186469 0.90 L3MBTL1 (0.38) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL21667598 0.90 LMNA (0.39) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL24252001 0.88 ALDH1A1 (0.43) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL18996717 0.87 TDP1 (0.44) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL21667416 0.87 L3MBTL1 (0.47) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL22868656 0.86 KDM4E (0.42) L3MBTL1KDM4ELMNAALDH1A1TDP1
SCHEMBL22186235 0.84 L3MBTL1 (0.48) L3MBTL1KDM4ELMNAALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 L3MBTL1 163/4885KDM4E 960/4885LMNA 2967/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.